Secretary Kennedy, Jr.’s Dismantling of the U.S. Department of Health and Human Services.
For decades, America’s national healthcare system and the broader U.S. biomedical scientific enterprise have sought to strengthen transparency, scientific integrity, and public trust in the pursuit of rigorous, evidence-based practice. Through sustained collaboration among clinicians, researchers, public health officials, and policymakers, the nation has realized substantial advances in the design and delivery of innovative clinical care and population health initiatives. At the same time, it remains widely recognized—both at home and abroad—that the United States continues to lag behind other high-income countries in overall health outcomes, due in significant measure to an aging population, limited access to primary health care, higher costs of care, and the growing prevalence of chronic disease. Nevertheless, Americans have generally remained supportive of the mission and services of the Department of Health and Human Services. Even when the COVID-19 pandemic laid bare serious weaknesses in the health delivery system—from vaccine supply and distribution challenges to workforce burnout and moral distress—public support for frontline healthcare professionals endured, reflecting continued respect for their professionalism, dedication, and commitment to patient care.
Following the change in administration in early 2025, President Donald Trump nominated Robert F. Kennedy Jr. to lead the vast and complex U.S. Department of Health and Human Services (HHS). As the federal government’s principal agency for safeguarding the health of the nation, HHS administers more than 100 programs across 11 operating divisions and carries broad responsibility for both public health and essential human services.
At its core, the mission of HHS is to:
-Protect the health of all Americans while providing essential human services.
- Enhance individual and community well-being through effective, evidence-based programs.
-Advance medical research, scientific discovery, and innovation.
-Ensure access to high-quality healthcare, particularly for underserved and vulnerable populations.
-Lead public health initiatives aimed at disease prevention and health promotion.
-Strengthen national preparedness and response capacity for public health emergencies.
Robert F. Kennedy Jr. has long been a vocal critic of the U.S. Department of Health and Human Services (HHS) and the federal public health establishment more broadly. He is best known for his sustained critiques of vaccine development, regulatory oversight, and immunization policy, often challenging the integrity of federal agencies and the scientific consensus supporting routine vaccination. Over time, he has argued that public health authorities have been overly influenced by pharmaceutical interests and insufficiently transparent in evaluating vaccine safety and efficacy. These positions have placed him in direct tension with mainstream public health institutions and much of the biomedical scientific community, while also garnering strong support among individuals skeptical of federal health policy.
During his Senate confirmation process, Kennedy spoke plainly about his intention to restructure the agency, warning that resistance from within would not be tolerated. At the same time, he pledged open and direct engagement with those willing to advance what he described as a renewed effort to “make America healthy again.” He promised Congress a receptive and collaborative working relationship and assured the public—whom he cited as the source of his mandate—that he would lead a new era of unbiased science, free from undisclosed conflicts of interest, secrecy, and profiteering. Central to his message was a commitment to restoring HHS’s authority through radical transparency, rigorous scientific standards, ethical integrity, compassion, professional competence, and renewed institutional pride.
Within a single year of Secretary Kennedy Jr.’s leadership, the structure and direction of HHS were significantly altered, reshaping an agency that for decades had played a central role in advancing the health and well-being of Americans. While the department had never been without flaws, it had long been regarded as a cornerstone of the nation’s public health and biomedical infrastructure. Across administrations, Americans generally relied on the career professionals within HHS to ground their work in established scientific standards—whether in matters of health and safety oversight, disease prevention, or the advancement of medical research.
A February 28 editorial in The Lancet catalogued a series of developments over the past year that, in its view, reflected a systematic weakening of the federal public health infrastructure. Among the concerns it identified were:
The dismissal from the NIAID of Director Dr. Jeanne Marrazzo, reportedly linked to her public affirmation of the extensive scientific evidence demonstrating that vaccines are safe and effective. The editorial framed her removal as emblematic of growing tensions between political leadership and established scientific consensus.
The suppression of a major federal report on alcohol and health, which had been expected to inform public health guidance but was never formally released, raising questions about transparency and evidence-based policymaking.
Shifts in U.S. vaccine policy, including changes to advisory processes and recommendations that, according to the editorial, departed from longstanding scientific norms and regulatory safeguards.
The amplification of misinformation, particularly around immunization and infectious disease control, which the editorial argued undermined public confidence in health institutions.
The prioritization of political objectives over public health considerations, with policy decisions increasingly framed in ideological rather than scientific terms.
Taken together, the editorial suggested that these actions signaled not isolated controversies, but a broader reorientation of federal health leadership away from traditional evidence-based governance.
What, then, might Americans expect from HHS over the next three years? If current patterns persist under the leadership of Robert F. Kennedy Jr., many observers anticipate continued turbulence, ongoing policy reversals, and further tension between political priorities and established scientific norms. Sustained uncertainty within the nation’s principal health agency risks eroding institutional stability, workforce morale, and public confidence—three elements essential to effective public health governance.
Restoring the U.S. Department of Health and Human Services to its former global stature will not be immediate or simple. It will require years of deliberate planning, disciplined implementation, rigorous oversight, and renewed commitment to scientific integrity. Rebuilding will also demand investment in workforce development, transparent advisory processes, strengthened partnerships with academic and international institutions, and innovation grounded firmly in evidence-based practice. Only through sustained structural and cultural renewal can HHS reassert its leadership in medical research, public health science, health professions education, and the design of equitable social service policy—roles it has historically played on both the national and global stage.
